Upload
discover-clinical-trials
View
4.477
Download
4
Tags:
Embed Size (px)
DESCRIPTION
© 2012 Barbara Cybart All Rights Reserved Contact Discover Clinical Trials for permission to use this material. Discover Clinical Trials Canada 3350 South Service Road Suite 301 Burlington, ON, L7N 3M6, Canada Contact Info T: +1 888-259-8059 F: + 1 905-631-0214 E: [email protected]
Citation preview
Systemic Lupus Erythematosus
(or SLE for short)
Name(s)______________________• Systemic Lupus Erythematosus• Abbreviations: SLS or Lupus• Alternative Names: Disseminated lupus
erythematosus; erythematosus; Discoid lupus
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Definition____________________
A chronic inflammatory condition caused by an autoimmune disease. An autoimmune disease occurs when the body's tissues are attacked by its own immune system. Patients with lupus have unusual antibodies in their blood that are targeted against their own body tissues.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Aetiology_____________________
• No definitive cause
BUT…
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Aetiology ____________________
Systemic Lupus Erythematosus
Inate Susceptibility•HLA type•Immunoregulatory genes•Hormonal levels•Complement levels
Environmental Stimuli•UV exposure•Microbial response•Medication
Autoimmune Proliferation•Hyperactive B-cell/T-cell activation•High ratio of CDA;CD8 T-cells•Defective immune complex clearance •Impaired tolerance
Autoantibody Production
•Apoptosis and self exposure•Self-recognition•Foreign-Ab cross reaction
Find out more about Asthma Treatment
Epidemiology____________________
• Prevalence of SLE in the population: 20 to 150 cases per 100,000
• In women, prevalence rates vary from: 164 (Caucasian) per 100,000
to 406 (African American) per 100,000
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Epidemiology____________________
• Due to improved detection of mild disease, the incidence nearly tripled in the last 40 years of the 20th century.
• Estimated incidence rates are 1 to 25 per 100,000 in North America, South America, Europe and Asia.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Epidemiology____________________
Geographic and racial distribution • More common in urban than rural areas• Prevalence of SLE is higher among: Asians, Afro-
Americans, Afro-Caribbeans, and Hispanic Americans compared with Americans of European decent in the United States and among Asian Indians compared with Caucasians in Great Britain. In comparison, SLE occurs infrequently in Blacks in Africa.
• In New Zealand, the prevalence and mortality of SLE are higher in Polynesians than in Caucasians.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Epidemiology____________________
Geographic and racial distribution (symptoms)• Photosensitivity and discoid skin lesions may be
more frequent clinical manifestations in patients with Northern European than those with Southern European ancestry; the former group is, however, less likely to have anti-cardiolipin and anti-dsDNA antibodies.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Epidemiology____________________
Gender• The increased frequency of SLE among women has
been attributed in part to an estrogen hormonal effect.
• In children, in whom sex hormonal effects are presumably minimal, the female-to-male ratio is 3:1.
• In adults, especially in women of child-bearing years, the ratio ranges from 7:1 to 15:1.
• In "older" individuals, especially post-menopausal women, the ratio is approximately 8:1.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Epidemiology____________________
Onset• Onset of SLE is usually after puberty, in 20s and 30s.• 20% of cases diagnosed during first 2 decades of life.
• Prevalence is highest among women 14-64 years old. • SLE does not have an age predilection in males,
although it should be noted that among older adults, the female-to-male ratio falls
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Pathogenesis__________________
• Autoimmune disorder • Characterized by multisystem microvascular
inflammation with the generation of autoantibodies.• Although the specific cause of SLE is unknown,
multiple factors are associated with the development of the disease, including genetic, racial, hormonal, and environmental factors
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Presenting Features____________
Systemic Lupus Erythematosus
• fever, rash, arthritis, alopecia, and renal involvement
Symptoms Occurrence
Achy joints (arthralgia) 95%
Fever more than 38 degrees C 90%
Rheumatoid arthritis 90%
Prolonged or extreme fatigue 81%
Skin rashes 74%
Anaemia 71%
Kindey involvement 50%
Pain in the chest on deep breathing (pleurisy) 45%
Find out more about Asthma Treatment
Arthritis (Swollen Joints)
Find out more about Asthma Treatment Systemic Lupus Erythematosus
Presenting Features____________
Systemic Lupus Erythematosus
• fever, rash, arthritis, alopecia, and renal involvement
Symptoms Occurrence
Butterfly-shaped rash across the cheeks and nose 42%
Sun or light sensitivity (photosensitivity) 30%
Hair loss 27%
Abnormal blood-clotting problems 20%
Raynaud’s phenomenon (fingers turning white and/or blue in the cold)
17%
Seizures 15%
Mouth or nose ulcers 12%
Find out more about Asthma Treatment
Butterfly Rash
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Raynaud’s Phenomenon
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Presenting Features____________
Systemic Lupus Erythematosus
Features Characteristics
Malar rash Fixed erythema, flat or raised, sparing the nasolabial folds
Discoid rash Erythematous raised patches with adherent keratotic scarring and follicular plugging
Photosensitivity Skin rash as a result of unusual reaction to sunlight
Oral ulcers Oral or nasopharyngeal ulceration; may be painless
Arthritis Non-erosive, involving two or more peripheral joints
Serositis a. Pleuritis (convincing history of pleuritic pain, rub or pleural effusion) or
b. Pericarditis (rub, ECG evidence or effusion)
Renal disorder a. Persistent proteinuria >0.5 g/day, or b. Cellular casts (red cell, granular or tubular)
Neurological disorder
Seizures or psychosis in the absence of offending drugs or metabolic derangement
Find out more about Asthma Treatment
Presenting Features____________
Systemic Lupus Erythematosus
Features Characteristics
Haematological disorder
a. Haemolytic anaemia orb. Leucopenia (<4000/mm3) orc. Lymphopenia (<1500/mm3) ord. Thrombocytopenia (<10 000/mm3) in the absence of
offending drugs
Immunology disorder
a. Anti-DNA antibodies in abnormal titre orb. Presence of antibody to Sm antigen or c. Positive antiphospholipid antibodies
Antinuclear antibody disorder
Abnormal titre of ANA by immunofluorescence
Find out more about Asthma Treatment
Complications (Blood)__________
Systemic Lupus Erythematosus
• Affects 85% of patients with SLE• 50% of patients have anemia• Between 34 - 42% of patients have
antiphospholipid syndrome (APS)• Patients who have APS have a high incidence
of blood clots• Blood clotting puts patients at higher risk for
stroke and pulmonary embolism
Find out more about Asthma Treatment
Clot in Deep Veins of Groin
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Complications (Heart & Circulation)
Systemic Lupus Erythematosus
• Heart disease is primary cause of death in lupus patients
• Atherosclerosis, or plaque buildup in the arteries• High blood pressure, most likely because of
kidney injury and corticosteroid treatments• Heart failure• Pericarditis, an inflammation of the tissue
surrounding the heart• Myocarditis, an inflammation of the heart muscle
itself (rare)
Find out more about Asthma Treatment
Complications (Lung)___________
Systemic Lupus Erythematosus
• Affects 60% of SLE patients• Inflammation of the membrane lining the lung
(pleurisy) is the most common problem, which can cause shortness of breath and coughing.
• In some cases, fluid accumulates, a condition called pleural effusion.
Find out more about Asthma Treatment
Complications (Kidney)__________
Systemic Lupus Erythematosus
• Affects 50% of patients• Poor kidney function (mild) and kidney failure
(severe) may result from this damage.• Serious complications occur in 30% of patients
Find out more about Asthma Treatment
Complications (CNS)____________
Systemic Lupus Erythematosus
• Nearly all patients complain of CNS complications• Most serious: inflammation of the blood vessels in the
brain (vasculitis), occurs in 10% of patients• Fever, seizures, psychosis, and even coma can occur. • Irritability• Emotional disorders (anxiety, depression)• Mild impairment of concentration and memory• Migraine and tension headaches• Problems with the reflex systems, sensation, vision,
hearing, and motor control
Find out more about Asthma Treatment
Complications (Other)___
Systemic Lupus Erythematosus
• Infections (common)• Gastrointestinal (45%)• Joint, Muscle, Bone (Osteoporosis, Arthritis)• Eye (5% temporary blindness)
Find out more about Asthma Treatment
Diagnosis_____________________
• Difficult to diagnose• No single diagnostic marker; identified through a
combination of clinal and laboratory criteria• Early diagnosis is important as it reduces morbidity
and mortality (lupus nephritis)
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Laboratory Investigations________
• 4 of 11 clinical and laboratory criteria must be met• Antinuclear antibody titer is the primary laboratory test • Antinuclear antibody titer of 1:40 and characteristic
multiorgan system involvement can be diagnosed with systemic lupus erythematosus without additional testing
• Patients with an antibody titer of 1:40 who fail to meet full clinical criteria should undergo additional testing: including tests for antibody to doublestranded DNA antigen and antibody to Sm nuclear antigen.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Treatment and Cure____________• No cure• Treatment goal: relieve symptoms and protect organs by
decreasing inflammation and/or the level of autoimmune activity in the body.
• Treatment options: Rest/Sleep Nonsteriodal anti-inflammatory drugs (taken with medication to
prevent ulcers) Corticosteriods (more potent than NSAIDs in reducing
inflammation) Hydroxychloroquine (anti-malarial) Cytotoxic drugs (immunosuppressive medications)
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Prognosis_____________________• Highly variable prognosis for individual
patients• Relatively benign to rapidly progressive/fatal
cases• Often waxes and wanes in affected individuals
throughout life, and features of the disease vary greatly between individuals.
Systemic Lupus ErythematosusFind out more about Asthma Treatment
Prevention____________________• There is currently no way to prevent SLE• But people who smoke may be more likely to
develop lupus.• Avoiding smoking and perhaps other tobacco
products may decrease your risk of developing lupus.
Systemic Lupus ErythematosusFind out more about Asthma Treatment